About Epoch Biodesign
Epoch Biodesign is a company based in London (United Kingdom) founded in 2019 by Jacob Nathan. Epoch Biodesign has raised $41.3 million across 4 funding rounds from investors including Gov.uk, Inditex and Lowercarbon. The company has 25 employees. Epoch Biodesign offers products and services including Biorecycling Platform and AI-Designed Enzymes.
- Headquarter London, United Kingdom
- Employees 25
- Founders Jacob Nathan
- SectorsTransportation, Automotive & Logistics
- Website epochbiodesign.com
- Social LinkedIn X
- Legal Name Epoch Biodesign Ltd
- Date of Incorporation 13 Feb, 2019
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$41.3M (USD)
in 4 rounds
- Latest Funding Round$12M (USD), Series A
Mar 2026
- InvestorsGov.uk
& 17 more
- Employee Count25
Products & Services of Epoch Biodesign
Epoch Biodesign offers a comprehensive portfolio of products and services, including Biorecycling Platform and AI-Designed Enzymes.
AI-driven platform for infinite recycling of plastics and textiles.
Enzymes that enable low-temperature recycling for mixed materials.
Funding Insights of Epoch Biodesign
Epoch Biodesign has successfully raised a total of $41.3M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $41.3M
- Total Rounds 4
- Last Round Series A — $12M
- First Round $11M
(Jun 2022)
- Investors Count 18
All 4 funding rounds of Epoch Biodesign with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2026 | $12M | Series A | – | – | |
| Mar 2025 | $1M | Grant | – | – | |
| Mar 2025 | $18.3M | Series A | – | Extantia | |
| Jun 2022 | $11M | Seed | – | Lowercarbon Capital |
18 investors in total: 18 institutional.
Investors in Epoch Biodesign
Epoch Biodesign has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Inditex and Lowercarbon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Extantia is focused on investing in climate technology pioneers. | – | extantia.com | - | |
Early-stage investments are targeted globally by this VC fund. | – | happinesscapital.com | Hong Kong, China | |
- | – | kiboinvest.com | - | |
Early-stage venture capital firm investing in and supporting technology startups | – | dayoneventures.com | San Francisco, United States | |
Venture capital fund focused on tech startups | – | lowercarboncapital.com | New York, United States | |
Early-stage deep technology investments are made by Amadeus Capital. | – | amadeuscapital.com | London, United Kingdom | |
- | – | zerocarbon.vc | - | |
Growth equity investments are made in B2B software companies by TVC Capital. | – | tvccapital.com | San Diego, USA | |
Investing in early-stage tech companies and ideas. | – | boxgroup.com | - | |
Venture capital fund focused on multiple sectors | – | theventurecollective.com | New York, United States |
Investor details for Epoch Biodesign
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Epoch Biodesign
5 people are tracked at Epoch Biodesign (2 in leadership, 3 in team); the tracked headcount is 25.
| Name | Role | Group |
|---|---|---|
Jacob Nathan | Founder & CEO | Leadership |
Beatriz Lopez | Chief People Officer | Leadership |
Charlotte Gruender | Business Development Manager | Team |
Angela Sims | R&D Operations Project Lead | Team |
Camila Gaspar Quinonez, PhD | Scientific Project Manager | Team |
Complete people profiles for Epoch Biodesign
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Epoch Biodesign
3 dated milestones of Epoch Biodesign across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Epoch Biodesign is founded.
- Funding First funding round of $11.0M.
- Funding Latest funding round, Series A, of $12.0M.
Web traffic of Epoch Biodesign
The website of Epoch Biodesign (epochbiodesign.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▲ 89.8% vs previous month
Latest news on Epoch Biodesign
Complete news archive for Epoch Biodesign
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Epoch Biodesign
10 companies that operate in the same segment as Epoch Biodesign (Air Management Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Indra is recognized as a global leader in transportation, air traffic, and defense solutions. | 1992 | Madrid, Madrid, Spain | USD 279.03 M | USD 6.42 B | 60,910 | |
Independent ratings and risk analytics for carbon projects are provided. | 2020 | London, England, United Kingdom | USD 109.21 M | – | – | |
Energy-based holding company | 1905 | United States | – | USD 24.42 B | 28,410 | |
HVAC and refrigeration systems are designed, manufactured, and sold worldwide. | 1871 | Swords, Fingal, Ireland | – | USD 21.32 B | 45,000 | |
Provider of indoor environmental management products | 1969 | Helsinki, Finland | USD 3 M | USD 497.75 K | 7 | |
Duct sealing services are provided to homes and industries. | 1993 | Miamisburg, Ohio, United States | USD 119 M | – | – | |
Ombudsman services for scientific misconduct in research are provided confidentially. | 1948 | Munchen, Bayern, Germany | – | – | – | |
Producer of net-zero natural gas, pursuing carbon-neutral energy solutions. This company focuses on making natural gas production carbon-neutral, a... | 2015 | Denver, Colorado, United States | USD 350.01 M | USD 1.15 B | 366 | |
Filtration products and solutions are manufactured for diverse industries. | 1942 | Austin, Texas, United States | – | – | 2,739 | |
Atmospheric carbon is removed via large-scale native reforestation projects. | 2021 | Sao Paulo, Brazil | USD 89.25 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Epoch Biodesign
Epoch Biodesign was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Epoch Biodesign is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jacob Nathan is the current CEO of Epoch Biodesign. They have also founded this company.
Epoch Biodesign is a funded company, having raised a total of $41.3M across 4 funding rounds to date. The company's 1st funding round was a Seed of $11M, raised on Jun 2022.
Epoch Biodesign has 25 employees.
Epoch Biodesign was founded in 2019 in London, United Kingdom. A biorecycling platform is operated by the company within the sustainability and materials science sector. Mixed plastics and textiles, including nylon and polyester, are processed using AI-designed enzymes for low-temperature recycling. Outputs are generated for applications in apparel, automotive, and packaging industries. Synthetic biology, process engineering, and AI are integrated to manage waste streams effectively.
Epoch Biodesign offers Biorecycling Platform and AI-Designed Enzymes.
Epoch Biodesign has 18 investors. Key investors include Gov.uk, Inditex, Lowercarbon, Voyagers, and Extantia.
Epoch Biodesign operates through Epoch Biodesign Ltd.